Search research articles
Contact Us
Filters
Showing results (271-280 of 280) with videos related to
Page
of 28
Sort By:
You have reached the last page of results.
This site can display upto 280 results.
Blood Cancer Discovery
|
February 1, 2023
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
Francesco Maura, Bachisio Ziccheddu, Jenny Z Xiang, et al.
Blood
|
July 27, 2016
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Anita Kumar, Carla Casulo, Joachim Yahalom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2021
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma
Anita Kumar, Carla Casulo, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2015
Hodgkin lymphoma, version 2.2015
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Cancer Discovery
|
June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Page
of 28
Search research articles
Search
Showing results (271-280 of 280) with videos related to
Sort By:
Page
of 28
You have reached the last page of results.
This site can display upto 280 results.
Blood Cancer Discovery
|
February 1, 2023
Molecular Evolution of Classic Hodgkin Lymphoma Revealed Through Whole-Genome Sequencing of Hodgkin and Reed Sternberg Cells
Francesco Maura, Bachisio Ziccheddu, Jenny Z Xiang, et al.
Blood
|
July 27, 2016
Brentuximab vedotin and AVD followed by involved-site radiotherapy in early stage, unfavorable risk Hodgkin lymphoma
Anita Kumar, Carla Casulo, Joachim Yahalom, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 28, 2021
Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma
Anita Kumar, Carla Casulo, Ranjana H Advani, et al.
Blood Cancer Journal
|
June 14, 2018
Integrated DNA/RNA targeted genomic profiling of diffuse large B-cell lymphoma using a clinical assay
Andrew M Intlekofer, Erel Joffe, Connie L Batlevi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 13, 2015
Hodgkin lymphoma, version 2.2015
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
March 11, 2018
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
May 7, 2017
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology
Richard T Hoppe, Ranjana H Advani, Weiyun Z Ai, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
Alison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Cancer Discovery
|
June 17, 2017
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes, Alessandro Pastore, Nicolaos Palaskas, et al.
Page
of 28